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abstract
Cardiovascular diseases  which comprise cardiac causes 
(most commonly ischemic heart disease and heart failure), 
cerebrovascular disease and other vascular conditions are the 
leading cause of death in Europe and worldwide. Despite a 
downward trend in cardiovascular mortality in many European 
countries, large disparities exist. Locally, cardiovascular mortality 
accounted for 40% of all deaths or 1298 deaths in 2013. 
introDuction
Global deaths from cardiovascular disease (CVD) are 
increasing as a result of population growth, the ageing of 
populations, and epidemiologic changes in disease.1 The World 
Health Organisation estimated that 31% of all deaths worldwide 
(17.5 million deaths) were caused by CVD in 2012,2 more than 
all communicable, maternal, neonatal and nutritional disorders 
combined, and double the number of deaths caused by cancers.3   
Global deaths from CVD increased by 41% between 1990 
and 2013 despite a 39% decrease in age-specific death rates; 
this increase was driven by a 55% increase in mortality due 
to the aging of the populations and a 25% increase due to 
population growth. The relative contribution of these drivers 
varied by region; only Central and Western Europe had gains 
in cardiovascular health that were sufficient to offset these 
demographic forces.1   
CVD is the leading cause of death in Europe, with 51% of 
women and 42% of men dying from this disease (40 of the 52 
countries provided data up to 2012). The gender difference in the 
proportional contribution of CVD is driven far more by stroke 
and other CVD rather than coronary heart disease. Three in every 
ten deaths of Europeans aged < 65 years and 37% of all deaths 
occurring < 75 years are attributable to CVD.4 
However, there are wide variations between countries in 
Europe. Some countries have identified cancer as being the 
commonest cause of death in men (e.g. Belgium, Denmark, 
France, Luxembourg, Netherlands, Portugal, Spain, Slovenia and 
San Marino) and for the first time, cancer has surpassed CVD as 
a cause of death among women in Denmark. In other countries 
(21 European countries) CVD deaths are more than double the 
cancer deaths in men and in another 6 countries, male CVD 
deaths are more than four times greater than cancer deaths.4      
tHe local situation
Deaths due to CVD contributed towards 40% of all deaths in 
2013 and represent the most common cause of death locally. This 
does not include deaths where the underlying cause of death is 
diabetes (usually represents between 3-5% of all deaths) where 
frequently, cardiovascular conditions also contribute to death.   
In 2013, deaths due to circulatory diseases represented 42% 
of deaths in females and 39% of deaths in males, showing a 
similar, however smaller gender disparity as found in Europe. 
This gender disparity is mainly due to cerebrovascular diseases 
and other heart diseases (mainly heart failure), while in deaths 
due to ischaemic heart disease there was a male predominance.
While CVDs  are still the commonest cause of death in 
Malta, they represented a much higher percentage of deaths in 
the past, where 60% of deaths in females and 55% of deaths in 
males were caused by CVD 30 years ago. 
Over the past 30 years (figure 1), following an initial decline 
in the number of deaths due to CVD in both gender, the total 
number of deaths has remained stable over the past 25 years. 
The total number of deaths in 2013 was 1298 while the number 
of deaths in 1989 was 1316. As described previously when 
considering mortality from any cause one has to take into 
account the effect of population growth as well as the aging of 
the population, apart from other epidemiological changes in 
CVD.   
The crude mortality rate which represents the total number 
of deaths from CVD divided by the total deaths and therefore 
is taking into consideration the increasing population size is 
showing a downward trend. However the greatest downward 
trend in cardiovascular mortality is being seen in the age 
standardised death rate in females despite the relative stable 
crude mortality rates from the early 1990s, indicating that 
people are dying at an older age.  
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Figure 1: Trends in total mortality, Crude Mortality Rate (CMR) and 
Standardised Death Rate of Circulatory Diseases over 30 years.5,6
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 Rates for CVD mortality for Malta compare well with 
the EU average for all CVDs  as seen in figure 2. Rates for 
cerebrovascular diseases are also similar to the EU average 
and have been so for the past 30 years. However rates for 
ischaemic heart disease are higher in Malta than the EU 
average, though the gap seems to be decreasing. In those 
countries where cancer supersedes cardiovascular mortality 
in males, all have lower mortality rates than Malta for 
circulatory disease.   
Discussion
The natural history of cardiovascular epidemics, 
including coronary heart disease, varies markedly among 
countries. Different coronary heart disease patterns are 
distinguishable including ‘rise and fall’ (classic epidemic 
pattern), ‘rising’ (first part of epidemic) and ‘flat’ (no 
epidemic yet).7 Malta followed the ‘rise and fall’ epidemic 
with increasing cardiovascular mortality rates till the late 
1970s-early 1980s followed by a fall from the 1980s onwards.
  Mortality rates continue to fall in most but not 
all European countries. Geographic inequalities in 
cardiovascular mortality continue to exist in Europe with 
countries like Norway, Denmark, France, Portugal, Spain and 
the Netherlands having the lowest rates of cardiovascular 
mortality.3 Mortality rates generally appear to be most closely 
linked to a country’s stage of epidemiological transition. 
This refers to the changes in the predominant forms of 
disease and mortality burdening a population that occur as 
its economy and health system develops. Underdeveloped 
countries are still in the early stages of epidemiological 
transition where infectious disease predominates,8 whereas at 
the other end, in countries with late stages of epidemiological 
transition, cancer mortality is superseding cardiovascular 
mortality.   
Studies examining the causes of the decline in CVD 
incidence and mortality in developed countries since the 
mid-1960s suggest that risk-factor reductions and treatment 
each account for between 40% and 60% of the reduction in 
CVD mortality, with undetermined causes accounting for an 
additional reduction of up to 10%.9,10 
From a policy and intervention perspective, a decreasing 
mortality trend does not necessarily mean we are seeing 
less deaths due to circulatory conditions. Locally, due to 
demographic trends, though mortality rates from CVDs 
continue to decline, the actual number of deaths has 
remained stable for a number of years. It is also interesting 
to note that hospital discharges due to CVDs have increased 
locally from 665 per 100,000 in 2001 to 1341 per 100,000 
in 2010,5 similar to the majority of European countries.  
This has obvious policy implications and emphasizes the 
continued high burden of CVD in European populations 
despite decreases in age-adjusted mortality rates.4 
Figure 2: Trends on standardised mortality rate in Malta compared 
to EU average for all circulatory diseases, ischaemic heart disease and 
cerebrovascular disease.5,6
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